{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:36Z","timestamp":1792787316783,"version":"4.5.0"},"reference-count":39,"publisher":"BMJ","issue":"4","funder":[{"name":"ALK-Abell\u00f3 A\/S, Denmark","award":["no award\/grant number"],"award-info":[{"award-number":["no award\/grant number"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,12,3]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypersensitivity to house dust mite (HDM) allergens is a common cause of allergic asthma symptoms and can be effectively treated with allergy immunotherapy (AIT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate whether genetic and type 2 (T2) inflammatory biomarkers correlate with disease severity in subjects with allergic asthma, and whether this can be modified by AIT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      MITRA (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01433523\">NCT01433523<\/jats:ext-link>\n                      ) was a phase III, randomised, double-blind, placebo-controlled trial of HDM sublingual immunotherapy (SLIT)-tablets in adults with HDM allergic asthma. Post hoc analyses of the study population (N=742) evaluated associations between T2 inflammatory (blood eosinophils, eosinophil cationic protein (ECP), total IgE and tryptase) and genetic (single-nucleotide polymorphisms, SNP) biomarkers (n=582) for the primary study endpoint (time to first moderate\/severe asthma exacerbation). SNP associations were verified in HDM-positive subgroup from an independent 3-year Severe Asthma Research Programme (SARP3) subject cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      An increased asthma exacerbation risk in subjects homozygous for SNP rs7216389 (chromosomal locus 17q12-21) was reduced (p\n                      <jats:italic>=<\/jats:italic>\n                      0.037) by treatment with HDM SLIT (HR=0.37 (95% CI 0.22 to 0.64), p&lt;0.001). The associations between exacerbation risk and 17q12-21 SNPs were replicated in the SARP3 HDM-positive subgroup. High levels of T2 biomarkers were associated with increased risk of asthma exacerbations in the placebo group. HDM SLIT-tablet treatment reduced this risk (blood eosinophils: HR=0.50 (95% CI 0.30 to 0.85); ECP: HR=0.45 (95% CI 0.29 to 0.87); tryptase: HR=0.45 (95% CI 0.25 to 0.80)). The treatment effect was higher (p\n                      <jats:italic>=<\/jats:italic>\n                      0.006) for subjects with a higher number of elevated T2 biomarkers.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>HDM SLIT-tablet AIT is efficacious in HDM-sensitised asthma subjects with a genetic asthma predisposition and\/or an underlying T2 endotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial results\" xlink:href=\"NCT01433523\">NCT01433523<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/thorax-2023-220707","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T13:20:33Z","timestamp":1703942433000},"page":"332-339","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Genetic and T2 biomarkers linked to the efficacy of HDM sublingual immunotherapy in asthma"],"prefix":"10.1136","volume":"79","clinical-trial-number":[{"clinical-trial-number":"nct01433523","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01433523","registry":"10.18810\/clinical-trials-gov","type":"results"},{"clinical-trial-number":"nct01433523","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Ilka","family":"Hoof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"B\u00f8nnelykke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stranzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed H","family":"Shamji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A","family":"Meyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Bleecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7615-8224","authenticated-orcid":false,"given":"Peter Sejer","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,12,30]]},"reference":[{"key":"2025042101250966000_79.4.332.1","unstructured":"Global Initiative for Asthma . Global strategy for asthma management and prevention. 2022. Available: https:\/\/ginasthma.org\/"},{"key":"2025042101250966000_79.4.332.2","doi-asserted-by":"publisher","DOI":"10.1080\/02770900802524657"},{"key":"2025042101250966000_79.4.332.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.10.012"},{"key":"2025042101250966000_79.4.332.4","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.jaci.2017.12.974","article-title":"A decade of research on the 17Q12-21 asthma locus: piecing together the puzzle","volume":"142","author":"Stein","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025042101250966000_79.4.332.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201507-1493OC"},{"key":"2025042101250966000_79.4.332.6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jaci.2017.07.044","article-title":"Cat exposure in early life decreases asthma risk from the 17Q21 high-risk variant","volume":"141","author":"Stokholm","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025042101250966000_79.4.332.7","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12880"},{"key":"2025042101250966000_79.4.332.8","doi-asserted-by":"publisher","DOI":"10.1038\/nri3786"},{"key":"2025042101250966000_79.4.332.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217343"},{"key":"2025042101250966000_79.4.332.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2021-217325"},{"key":"2025042101250966000_79.4.332.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201208-1414OC"},{"key":"2025042101250966000_79.4.332.12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025042101250966000_79.4.332.13","doi-asserted-by":"publisher","DOI":"10.1081\/JAS-120002288"},{"key":"2025042101250966000_79.4.332.14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2249.2010.04148.x","article-title":"T-cell responses induced by allergen-specific immunotherapy","volume":"161","author":"Maggi","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2025042101250966000_79.4.332.15","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.jaci.2017.10.010","article-title":"Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers","volume":"140","author":"Shamji","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2025042101250966000_79.4.332.16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2025042101250966000_79.4.332.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.03.019"},{"key":"2025042101250966000_79.4.332.18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.3964"},{"key":"2025042101250966000_79.4.332.19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/cea.13686","article-title":"Association between biomarkers and house dust mite sublingual immunotherapy in allergic asthma","volume":"50","author":"Hoshino","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"2025042101250966000_79.4.332.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.12.013"},{"key":"2025042101250966000_79.4.332.21","doi-asserted-by":"crossref","DOI":"10.1186\/s13742-015-0047-8","article-title":"Second-generation PLINK: rising to the challenge of larger and richer datasets","volume":"4","author":"Chang","year":"2015","journal-title":"Gigascience"},{"key":"2025042101250966000_79.4.332.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.11.020"},{"key":"2025042101250966000_79.4.332.23","doi-asserted-by":"publisher","DOI":"10.1086\/521987"},{"key":"2025042101250966000_79.4.332.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2025042101250966000_79.4.332.25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaci.2020.07.030","article-title":"Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways","volume":"147","author":"Li","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"2025042101250966000_79.4.332.26","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaip.2017.05.032","article-title":"Baseline features of the severe asthma research program (SARP III) cohort: differences with age","volume":"6","author":"Teague","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025042101250966000_79.4.332.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31324-1"},{"key":"2025042101250966000_79.4.332.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31322-8"},{"key":"2025042101250966000_79.4.332.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1304048"},{"key":"2025042101250966000_79.4.332.30","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2025042101250966000_79.4.332.31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0258(20001015)19:19<2595::AID-SIM562>3.0.CO;2-M"},{"key":"2025042101250966000_79.4.332.32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/all.12537","article-title":"17Q21 gene variation is not associated with asthma in adulthood","volume":"70","author":"Kreiner-M\u00f8ller","year":"2015","journal-title":"Allergy"},{"key":"2025042101250966000_79.4.332.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1211592"},{"key":"2025042101250966000_79.4.332.34","doi-asserted-by":"publisher","DOI":"10.1038\/nature06014"},{"key":"2025042101250966000_79.4.332.35","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1111\/all.15243","article-title":"House dust mite sensitization and exposure affects bronchial epithelial anti-microbial response to viral stimuli in patients with asthma","volume":"77","author":"Cerps","year":"2022","journal-title":"Allergy"},{"key":"2025042101250966000_79.4.332.36","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1164\/rccm.202209-1708OC","article-title":"Allergen Immunotherapy enhances airway epithelial antiviral immunity in patients with allergic asthma (VITAL study): a double blind randomized controlled trial","volume":"207","author":"Woehlk","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2025042101250966000_79.4.332.37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005765","article-title":"Impaired sphingolipid synthesis in the respiratory tract induces airway hyperreactivity","volume":"5","author":"Worgall","year":"2013","journal-title":"Sci Transl Med"},{"key":"2025042101250966000_79.4.332.38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms3479","article-title":"ORMDL3 promotes eosinophil trafficking and activation via regulation of integrins and CD48","volume":"4","author":"Ha","year":"2013","journal-title":"Nat Commun"},{"key":"2025042101250966000_79.4.332.39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-2600(20)30011-4","article-title":"Expression quantitative trait locus fine mapping of the 17Q12-21 asthma locus in African American children: a genetic association and gene expression study","volume":"8","author":"Ober","year":"2020","journal-title":"Lancet Respir Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T06:59:54Z","timestamp":1745218794000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,30]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/thorax-2023-220707"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220707","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,30]]}}}